CRISPR RNA-editing therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRISPR RNA-editing therapy, covering 2024-11-26 to 2024-11-26. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO) [NA]